Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L10 pseudogene 15 (RPL10P15) is annotated as a pseudogene homologous to the ribosomal protein L10 gene. It is not protein-coding, and there is no evidence for its expression or functional role in cellular biology. Pseudogenes like RPL10P15 are typically the result of gene duplication or retrotransposition events and generally lack the ability to produce functional proteins. There are no disease associations, therapeutic roles, or drug interactions known for this pseudogene[2].
None - no mechanisms reported, as pseudogenes are not targeted by drugs
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L10 pseudogene 15 (RPL10P15).